Wolverine Trading, LLC Alkermes Plc. Put Options Transaction History

Wolverine Trading, LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2025 May 15, 2025	SELL	$28.08 - $36.0 $81,432 - $104,400	-2,900 Reduced 23.02%	9,700 $320,000
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $20,560 - $25,168	800 Added 6.78%	12,600 $362,000
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $271,518 - $336,890	11,800 New	11,800 $330,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $438,240 - $540,496	16,600 New	16,600 $449,000
Q3 2023 Nov 15, 2023	SELL	$27.17 - $31.97 $81,510 - $95,910	-3,000 Reduced 26.55%	8,300 $232,000
Q2 2023 Aug 23, 2023	BUY	$28.34 - $33.63 $320,242 - $380,019	11,300 New	11,300 $353,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $207,630 - $251,910	9,000 Added 89.11%	19,100 $507,000
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $216,847 - $324,008	10,100 New	10,100 $236,000
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $315,495 - $433,755	-13,500 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$18.78 - $25.15 $133,338 - $178,565	-7,100 Reduced 34.47%	13,500 $328,000
Q1 2021 May 14, 2021	BUY	$18.21 - $23.2 $96,513 - $122,960	5,300 Added 34.64%	20,600 $386,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $451,560 - $580,191	-15,900 Reduced 50.96%	15,300 $558,000
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $1.43 Million - $2.29 Million	-51,300 Reduced 62.18%	31,200 $889,000
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $3.18 Million - $3.8 Million	82,500 New	82,500 $3.5 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $1.15 Million - $1.44 Million	-21,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $1.02 Million - $1.19 Million	21,400	21,400 $1.17 Million

403

176M

229K

436K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.59B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.